Lethal congenital toxoplasmosis resulting from reactivation of toxoplasmosis in a pregnant HIV seropositive patient [2];Toxoplasmose congénitale mortelle consécutive à une toxoplasmose de réactivation survenue chez une parturiente séropositive pour le VIH [2]

Presse Medicale

Volumn 31, Issue 33, 2002, Pages 1558-

  Marty, Pierre ^a   Bongain, A ^a   Loiseau, S ^a   Benoit, B ^a   Chevallier, A ^a   Gillet, J Y ^a   Le Fichoux, Y ^a  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CASE REPORT; CONGENITAL TOXOPLASMOSIS; FEMALE; FETUS DEATH; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE DEFICIENCY; LETTER; PREGNANCY; RECURRENT DISEASE; TOXOPLASMA GONDII; VIRUS REACTIVATION;

ADULT; FATAL OUTCOME; FEMALE; FETAL DEATH; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; TOXOPLASMOSIS, CONGENITAL;

EID: 0037069129     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (4)

1. Marty P., Bongain A., Rahal A et al. Prenatal diagnosis of severe fetal toxoplasmosis as a result of toxoplasmic reactivation in an HIV 1 seropositive woman. Prenatal Diagnosis 1994; 14: 414-15.
2. European Collaborative Study and Research Network on congenital toxoplasmosis. Low incidence of congenital toxoplasmosis in children born to women infected with human immunodeficiency virus. Eur J Obstet Gynecol Reprod Biology 1996; 68: 93-6.
3. Heddana H L, Mitchell J L, Brown G M, Williams S B. Normal fetal outcome in a pregnancy with central nervous system toxoplasmosis and human immunodeficiency virus infection. A case report J Reprod Med, 1993; 38; 747-50
4. Derouin F, Jacqz-Aigrain E, Thuiliez P, Couvreur J, Leport C. Cotrimoxazole for prenatal treatment of congenital toxoplasmosis. Parasitology Today, 2000; 16: 254-6